Recording
Re-regulation, not Deregulation: A 21st Century Framework for Biotech Policy
With Dean Woodley Ball
Biotechnology advances won’t just transform healthcare; they’ll also transform the regulation of healthcare. How should regulators treat drugs intended to lengthen human lifespans, an endpoint which is, by definition, difficult to measure in a human clinical trial? How will the clinical trial system adapt as therapeutics become increasingly personalized? We don’t need tweaks to answer these questions; we need wholesale reimagining of the regulatory structure of the pharmaceutical industry. This talk will lay out a few tentative options for doing so.